Maninder Hora
2017
In 2017, Maninder Hora earned a total compensation of $4.7M as Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer at Nektar Therapeutics, a 203% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $353,625 |
|---|---|
| Option Awards | $2,118,510 |
| Salary | $471,500 |
| Stock Awards | $1,706,998 |
| Other | $15,394 |
| Total | $4,666,027 |
Hora received $2.1M in option awards, accounting for 45% of the total pay in 2017.
Hora also received $353.6K in non-equity incentive plan, $471.5K in salary, $1.7M in stock awards and $15.4K in other compensation.
Rankings
In 2017, Maninder Hora's compensation ranked 2,082nd out of 14,666 executives tracked by ExecPay. In other words, Hora earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,082 out of 14,666 | 86th |
Division Manufacturing | 714 out of 5,770 | 88th |
Major group Chemicals And Allied Products | 192 out of 2,074 | 91st |
Industry group Drugs | 145 out of 1,730 | 92nd |
Industry Pharmaceutical Preparations | 112 out of 1,329 | 92nd |
Source: SEC filing on April 30, 2018.
Hora's colleagues
We found four more compensation records of executives who worked with Maninder Hora at Nektar Therapeutics in 2017.
2017
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2017
John Nicholson
Nektar Therapeutics
Chief Operating Officer
2017
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2017
Stephen Doberstein
Nektar Therapeutics